We present a critical perspective of the impact of gender differences on a widely accepted model of ketamine psychosis in healthy volunteers. Male and female patients with schizophrenia present with different symptomatology, disease course and response to pharmacological intervention. Accordingly, it is expected that ketamine psychosis in healthy volunteers fulfils this face validity. Pre-clinical studies in rats indicate a gender difference in response to ketamine administration. However, a review of the literature to date indicates that studies carried out in healthy volunteers have used all male or mixed samples, indicating the need for further studies comparing the psychopathological effects of ketamine in males and females.
Abel K M , Allin M , Geyer M (2000) Subanaesthetic ketamine in healthy male volunteers: effects of sensorimotor gating, cognitive performance and perception . Schizophr Res41: 236-236
2.
Abel K M , Allin M P , Hemsley D R , Geyer M A (2003) Low dose ketamine increases prepulse inhibition in healthy men . Neuropharmacology44: 729–737
3.
Adler C M , Goldberg T E , Malhotra A K , Pickar D , Breier A (1998) Effects of ketamine on thought disorder, working memory, and semantic memory in healthy volunteers . Biol Psychiatry43: 811–816
4.
Aleman A , Kahn R S , Selten J P (2003) Sex differences in the risk of schizophrenia . Arch Gen Psychiatry60: 565–571
5.
Anand A , Charney D S , Oren D A , Berman R M , Hu X S , Cappiello A , Krystal J H (2000) Attentuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutaminergic effects of N-methyl-D-aspartate receptor antagonists . Arch Gen Psychiatry57: 270–276
6.
Breier A , Malhotra A K , Pinals D A , Weisenfeld N I , Pickar D (1997) Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers . Am J Psychiatry154: 805–811
7.
Breier A , Adler C M , Weisenfeld N , Su T P , Elman I , Picken L , Malhotra A K , Pickar D (1998) Effects of NMDA antagonism on striatal dopamine release in healthy subjects: application of a novel PET approach . Synapse29: 142–147
8.
Farber N B , Hanslick J , Kirby C , McWilliams L , Olney J W (1998) Serotonergic agents that activate 5HT2A receptors prevent NMDA antagonist neurotoxicity . Neuropsy chopharmacology18: 57–62
9.
Hetem L A B , Danion J M , Diemunsch P , Brandt C (2000) Effect of subanaesthetic dose of ketamine on memory and conscious awareness in healthy volunteers . Psychopharmacology152: 283–288
10.
Jansen K L (2000) A review of the non-medical use of ketamine: use, users and consequences . J Psychoact Drugs32: 419–433
11.
Kegeles L S , Abi-Dargham A , Zea-Ponce Y , Rodenhiser-Hill J , Mann J J , Van Heertum R L , Cooper T B , Carlsson A , Laruelle M (2000) Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia . Biol Psychiatry48: 627–640
12.
Krystal J H , Karper L P , Seibyl J P , Freeman G K , Delaney R , Bremner J D , Heninger G R , Bowers M B , Charney D S (1994) Subanaesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses . Arch Gen Psychiatry51: 199–214
13.
Lahti A C , Weiler M A , Michaelidis T , Parwani A , Tamminga C A (2001) Effects of ketamine in normal and schizophrenic volunteers . Neuropsychopharmacology25: 455–467
14.
Malhotra A K , Pinals D A , Weingartner H , Sirocco K , Missar C D , Pickar D , Breier A (1996) NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers . Neuropsychopharmacology14: 301–307
15.
Maric N , Krabbendam L , Vollebergh W , De Graaf R , Van Os J (2002) Sex differences in symptoms of psychosis in a non-selected, general population sample . Schizophr Res1825: 1–7
16.
Micallef J , Guillermain Y , Tardieu S , Hasbroucq T , Possamai C , Jouve E , Blin O (2002) Effects of subanaesthetic doses of ketamine on sensorimotor information processing in healthy subjects . Clin Neuropharmacol25: 101–106
17.
Newcomer J W , Farber N B , Jevtovic-Todorovic V , Selke G , Melson A K , Hershey T , Craft S , Olney J W (1999) Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis . Neuropsychopharmacology20: 106–118
18.
Riecher-Rössler A (2002) Oestrogen effects in schizophrenia and their potential therapeutic implications – review . Arch Women Ment Health5: 111–118
19.
Riecher-Rössler A , Häfner H , Dütsch-Strobel A , Oster M , Stumbaum M , Van Gülick-Bailer M , Löffler W (1994) Further evidence for a specific role of estradiol in schizophrenia?Biol Psychiatry36: 492–495
20.
Sharp F R , Butman M , Aardalen K , Nickolenko J , Nakki R , Massa S M , Swanson R A , Sagar S M (1994) Neuronal injury produced by NMDA antagonists can be detected using heat shock proteins and can be blocked with antipsychotics . Psychopharmacol Bull30: 555–560
21.
Sobell J L , Mikesell M J , McMurray C T (2002) Genetics and Etiopathophysiology of Schizophrenia . Mayo Clin Proc77: 1068–1082
22.
Umbricht D , Schmid L , Koller R , Vollenweider F X , Hell D , Javitt D C (2000) Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia . Arch Gen Psychiatry57: 1139–1147
23.
Umbricht D , Koller R , Vollenweider F X , Schmid L (2002) Mismatch negativity predicts psychotic experiences induced by NMDA receptor antagonist in healthy volunteers . Biol Psychiatry51: 400–406
24.
Van Berckel B N , Oranje B , Van Ree J M , Verbaten M N , Kahn R S (1998) The effects of low dose ketamine on sensory gating, neuroendocrine secretion and behaviour in healthy human subjects . Psychopharmacology137: 271–281
25.
Weiler M A , Thaker G K , Lahti A C , Tamminga C A (2000) Ketamine effects on eye movements . Neuropsychopharmacology23: 645–653
26.
Winters W D , Hance A J , Cadd G C , Lakin M (1986) Seasonal and sex influences on ketamine-induced analgesia and catalepsy in the rat; a possible role for melatonin . Neuropharmacology25: 1095–1101
